Trademark Overview
On Thursday, April 30, 2026, a trademark application was filed for REGENEZONE with the United States Patent and Trademark Office. The USPTO has given the REGENEZONE trademark a serial number of 99798046. The federal status of this trademark filing is NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER as of Thursday, April 30, 2026. This trademark is owned by Iluminar PLLC. The REGENEZONE trademark is filed in the Medical & Beauty Services & Agricultural Services category with the following description:
Stem cell therapy services; Physician services; Medical clinic services; Regenerative medicine services; Consultancy in the field of the medical treatment of pain relief and management; Wellness and health-related consulting services; Health care consulting in the field of pain relief and management; Medical services, namely, platelet-rich plasma injection therapy; Medical services, namely, proliferative therapy; Medical services, namely, acoustic wave therapy
